» Articles » PMID: 20237196

Identification of Immunodominant B- and T-cell Combined Epitopes in Outer Membrane Lipoproteins LipL32 and LipL21 of Leptospira Interrogans

Overview
Date 2010 Mar 19
PMID 20237196
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Leptospirosis is a serious infectious disease caused by pathogenic Leptospira. B- and T-cell-mediated immune responses contribute to the mechanisms of Leptospira interrogans infection and immune intervention. LipL32 and LipL21 are the conserved outer membrane lipoproteins of L. interrogans and are considered vaccine candidates. In this study, we identified B- and T-cell combined epitopes within LipL32 and LipL21 to further develop a novel vaccine. By using a computer prediction algorithm, two B- and T-cell combined epitopes of LipL21 and four of LipL32 were predicted. All of the predicted epitopes were expressed in a phage display system. Four epitopes, LipL21 residues 97 to 112 and 176 to 184 (LipL21(97-112) and LipL21(176-184), respectively) and LipL32(133-160) and LipL32(221-247) of LipL32 were selected as antigens by Western blotting and enzyme-linked immunosorbent assay. These selected epitopes were also recognized by CD4(+) T lymphocytes derived from LipL21- or LipL32-immunized BALB/c (H-2(d)) mice and mainly polarized the immune response toward a Th1 phenotype. The identification of epitopes that have both B- and T-cell immune reactivities is of value for studying the immune mechanisms in response to leptospiral infection and for designing an effective vaccine for leptospirosis.

Citing Articles

Characterization of the monoclonal antibody and the immunodominant B-cell epitope of African swine fever virus pA104R by using mouse model.

Chen Q, Liu L, Guo S, Li L, Yu Y, Liu Z Microbiol Spectr. 2024; 12(3):e0140123.

PMID: 38305163 PMC: 10913377. DOI: 10.1128/spectrum.01401-23.


The leptospiral OmpA-like protein (Loa22) is a surface-exposed antigen that elicits bactericidal antibody against heterologous .

Schuler E, Patel D, Marconi R Vaccine X. 2023; 15:100382.

PMID: 37727366 PMC: 10506094. DOI: 10.1016/j.jvacx.2023.100382.


Exploring Leptospiral proteomes to identify potential candidates for vaccine design against Leptospirosis using an immunoinformatics approach.

Lata K, Kumar S, Vaghasia V, Sharma P, Bhairappanvar S, Soni S Sci Rep. 2018; 8(1):6935.

PMID: 29720698 PMC: 5932004. DOI: 10.1038/s41598-018-25281-3.


Pathogenic : Advances in understanding the molecular pathogenesis and virulence.

Ghazaei C Open Vet J. 2018; 8(1):13-24.

PMID: 29445617 PMC: 5806663. DOI: 10.4314/ovj.v8i1.4.


Human leptospirosis vaccines in China.

Xu Y, Ye Q Hum Vaccin Immunother. 2017; 14(4):984-993.

PMID: 29148958 PMC: 5893195. DOI: 10.1080/21645515.2017.1405884.


References
1.
Christova I, Tasseva E, Manev H . Human leptospirosis in Bulgaria, 1989-2001: epidemiological, clinical, and serological features. Scand J Infect Dis. 2004; 35(11-12):869-72. DOI: 10.1080/00365540310016709. View

2.
Wang L, Yu M . Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics. Curr Drug Targets. 2004; 5(1):1-15. DOI: 10.2174/1389450043490668. View

3.
Lin X, Chen Y, Lu Y, Yan J, Yan J . Application of a loop-mediated isothermal amplification method for the detection of pathogenic Leptospira. Diagn Microbiol Infect Dis. 2008; 63(3):237-42. DOI: 10.1016/j.diagmicrobio.2008.10.012. View

4.
Kaur M, Chug H, Singh H, Chandra S, Mishra M, Sharma M . Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis. Mol Immunol. 2009; 46(10):2107-15. DOI: 10.1016/j.molimm.2008.12.031. View

5.
de Souza A, Sztajnbok J, Marques S, Seguro A . Leptospirosis-induced meningitis and acute renal failure in a 19-month-old male child. J Med Microbiol. 2006; 55(Pt 6):795-797. DOI: 10.1099/jmm.0.46486-0. View